RNA, 7SL, cytoplasmic 632, pseudogene (RN7SL632P)

**RNA, 7SL, cytoplasmic 632, pseudogene (RN7SL632P)** is classified as a pseudogene, specifically a non-coding RNA pseudogene related to 7SL RNA, which is the RNA component of the signal recognition particle (SRP). Unlike the functional 7SL RNA gene, RN7SL632P is one of hundreds of 7SL RNA-like sequences dispersed throughout the human genome that have lost coding capacity due to truncations and mutations, arising from the reverse flow of genetic information from RNA back into DNA. It is not transcribed into a functional ribonucleoprotein and does not have a recognized biological function, structural role, or direct disease relevance as a protein-coding gene or therapeutic target[1][8][9]. The majority of these 7SL RNA pseudogenes are believed to be evolutionary remnants and are not expressed or functional in human cells. **Key points:** - This is a *pseudogene* and not a protein, enzyme, receptor, or clinically actionable target. - 7SL RNA pseudogenes like RN7SL632P arise by reverse transcription of RNA into DNA and reintegration into the genome[8][9]. - Unlike functional 7SL RNA, which forms part of the signal recognition particle responsible for targeting proteins to membranes, RN7SL632P does not participate in any characterized cellular process or disease mechanism[5][7][8]. - Occasionally, pseudogene-derived RNAs can have regulatory functions, such as acting as competing endogenous RNAs (ceRNAs) or producing small interfering RNAs, but there is no reported evidence of such a role for RN7SL632P specifically[4]. RN7SL632P is not a therapeutic target or clinically relevant biomolecule; it is best described as a biologically inactive, non-coding pseudogene[1][6][7][8][9].

Other names

RN7SL632P